An association between type 1 diabetes and idiopathic generalized epilepsy [7]

Annals of Neurology

Volumn 59, Issue 4, 2006, Pages 728-

  Vulliemoz, Serge ^a   Seeck, Margitta ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; AUTOIMMUNE DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; GENERALIZED EPILEPSY; HUMAN; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SEIZURE THRESHOLD;

ANTIBODIES; DIABETES MELLITUS, TYPE 1; EPILEPSY, GENERALIZED; GLUTAMATE DECARBOXYLASE; HUMANS;

EID: 33645763647     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20830     Document Type: Letter

References (5)

1. McCorry D, Nicolson A, Smith D, et al. An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 2006;59:204-206.
2. Baekkeskov S, Aanstoot HJ, Christgau S, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-156.
3. Vianello M, Tavolato B, Giometto B. Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci 2002;23:145-151.
4. Kwan P, Sills GJ, Kelly K, et al. Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 2000;42:191-195.
5. Yoshimoto T, Doi M, Fukai N, et al. Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of antiglutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Intern Med 2005;44:1174-1177.